Literature DB >> 8733580

Blockade of porcine carotid vascular response to sumatriptan by GR 127935, a selective 5-HT1D receptor antagonist.

P De Vries1, J P Heiligers, C M Villalón, P R Saxena.   

Abstract

1. It has previously been shown that the antimigraine drug, sumatriptan, a putative 5-HT1D receptor agonist, decreases porcine common carotid and arteriovenous anastomotic blood flows, but slightly increases the arteriolar (capillary) blood flow to the skin and ears. Interestingly, such responses, being mediated by 5-HT1-like receptors, are resistant to blockade by metergoline, which, in addition to displaying a very high affinity for (and occasionally intrinsic efficacy at) the 5-HT1D receptor subtypes, blocks (with lower potency than methiothepin) some 5-HT1D receptor-mediated vascular responses. These findings raise doubts whether sumatriptan-sensitive 5-HT1-like receptors mediating changes in the distribution of porcine carotid blood flow are identical to cloned 5-HT1D receptors. With the recent advent of the potent and selective 5-HT1D receptor antagonist, GR127935, we have examined in the present study whether the carotid vascular effects of sumatriptan in the pig are amenable to blockade by GR127935. 2. In animals pretreated with saline, sumatriptan (30, 100 and 300 micrograms kg-1, i.v.) reduced the total carotid and arteriovenous anastomotic blood flows in a dose dependent manner. In contrast, sumatriptan increased blood flow to the skin, ears and fat, although the total capillary fraction was not significantly affected. 3. While GR127935 pretreatment (0.25 and 0.5 mg kg-1) itself slightly reduced the total carotid and arteriovenous anastomotic blood flows, carotid vasoconstrictor responses to sumatriptan were either partly (0.25 mg kg-1) or completely (0.5 mg kg-1) blocked by the compound. In GR127935 pretreated animals, the sumatriptan-induced increases in blood flow to the skin, ears and fat were also attenuated. 4. Taken together, the results suggest that arteriovenous anastomotic constriction and, possibly, arteriolar dilatation in the skin, ears and fat by sumatriptan are mediated by 5-HT1D receptors. Therefore, vascular 5-HT1-like receptors in the porcine carotid bed appear to be identical to 5-HT1D receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733580      PMCID: PMC1909483          DOI: 10.1111/j.1476-5381.1996.tb15370.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors.

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

2.  Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances.

Authors:  P R Saxena; H C Schamhardt; R P Forsyth; J Hoeve
Journal:  Comput Programs Biomed       Date:  1980-12

3.  The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs.

Authors:  W Feniuk; P P Humphrey; M J Perren
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

4.  5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.

Authors:  P Schoeffter; D Hoyer
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

5.  Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites.

Authors:  S J Peroutka; B G McCarthy
Journal:  Eur J Pharmacol       Date:  1989-04-12       Impact factor: 4.432

6.  Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs.

Authors:  C M Villalón; E Ramírez-San Juan; C Castillo; E Castillo; F J López-Muñoz; J A Terrón
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

7.  The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra.

Authors:  P Schoeffter; C Waeber; J M Palacios; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

8.  GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.

Authors:  P P Humphrey; W Feniuk; M J Perren; H E Connor; A W Oxford; L H Coates; D Butina
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

9.  Systemic and regional hemodynamic effects of the putative 5-HT1A receptor agonist flesinoxan in the cat.

Authors:  G H Dreteler; W Wouters; P R Saxena
Journal:  J Cardiovasc Pharmacol       Date:  1989-11       Impact factor: 3.105

10.  Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes.

Authors:  C Waeber; P Schoeffter; J M Palacios; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

View more
  12 in total

1.  Operational characteristics of the 5-HT1-like receptors mediating external carotid vasoconstriction in vagosympathectomized dogs. Close resemblance to the 5-HT1D receptor subtype.

Authors:  C M Villalón; A Sánchez-López; D Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  The effect of supplemental 70% oxygen on postoperative nausea and vomiting in patients undergoing inguinal hernia surgery.

Authors:  S H Sadrolsadat; M Shoroghi; F Farahbakhsh; R Shariat Moharreri; M Sheikhvatan; A Abbasi
Journal:  Hernia       Date:  2007-11-17       Impact factor: 4.739

3.  Pharmacological evidence that alpha1-and alpha2-adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs.

Authors:  E W Willems; M Trion; P De Vries; J P Heiligers; C M Villalón; P R Saxena
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 4.  Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Authors:  P Tfelt-Hansen; P De Vries; P R Saxena
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

5.  A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle.

Authors:  Karuppiah Chockalingam; Rudo L Simeon; Charles M Rice; Zhilei Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

6.  Molecular cloning, sequence analysis and pharmacological properties of the porcine 5-HT(1D) receptor.

Authors:  P Bhalla; H S Sharma; T Wurch; P J Pauwels; P R Saxena
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

7.  Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses.

Authors:  P De Vries; E W Willems; J P Heiligers; C M Villalón; P R Saxena
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

8.  Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.

Authors:  C M Villalón; P De Vries; G Rabelo; D Centurión; A Sánchez-López; P Saxena
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

9.  Comparative effects of frovatriptan and sumatriptan on coronary and internal carotid vascular haemodynamics in conscious dogs.

Authors:  I Carel; B Ghaleh; A Edouard; J L Dubois-Rande; A A Parsons; J F Giudicelli; A Berdeaux
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

Review 10.  A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.

Authors:  Sheena K Aurora; Stephen B Shrewsbury; Sutapa Ray; Nada Hindiyeh; Linda Nguyen
Journal:  Headache       Date:  2021-04-01       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.